Literature DB >> 19758339

Isolation of human eosinophils: microbead method has no impact on IL-5 sustained viability.

Caroline M Percopo, Kimberly D Dyer, Kristin E Killoran, Helene F Rosenberg.   

Abstract

BACKGROUND/
PURPOSE: In a recent issue of Experimental Dermatology (18, 2009, 654), Schefzyk et al. concluded that multi-antibody eosinophil isolation (Miltenyi) should be abandoned, as differential purity was minimal, and eosinophils underwent accelerated apoptosis when compared with those isolated with traditional anti-CD16 microbeads. Our intent was to investigate the universality of these findings.
METHODS: We isolated eosinophils from normal donor granulocyte packs using two methods, and evaluated purity, viability and annexin-V/propidium-iodide staining.
RESULTS: Purity was substantially greater when multi-antibody isolation was used for eosinophil isolation from granulocyte packs (98% vs 69%). No differential survival was detected when eosinophils were maintained in culture with or without interleukin-5.
CONCLUSIONS: Multi-antibody eosinophil isolation represents a substantial advantage over anti-CD-16 microbeads when isolating large numbers of eosinophils from concentrated leucocyte preparations. No differential survival was observed. While appropriate consideration of methods is always crucial, multi-antibody eosinophil isolation should not be abandoned completely.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19758339      PMCID: PMC2878395          DOI: 10.1111/j.1600-0625.2009.00974.x

Source DB:  PubMed          Journal:  Exp Dermatol        ISSN: 0906-6705            Impact factor:   3.960


  7 in total

1.  Eosinophils isolated by magnetic cell sorting respond poorly to lipid chemoattractants.

Authors:  T B Casale; R A Erger; M D Rozell
Journal:  Ann Allergy Asthma Immunol       Date:  1999-08       Impact factor: 6.347

2.  Effect of isolation protocol on eosinophil function: Percoll gradients versus immunomagnetic beads.

Authors:  J B Sedgwick; Y Shikama; M Nagata; K Brener; W W Busse
Journal:  J Immunol Methods       Date:  1996-10-30       Impact factor: 2.303

3.  Eosinophils inhibit retroviral transduction of human target cells by a ribonuclease-dependent mechanism.

Authors:  J B Domachowske; H F Rosenberg
Journal:  J Leukoc Biol       Date:  1997-09       Impact factor: 4.962

4.  Isolation technique alters eosinophil migration response to IL-8.

Authors:  M D Rozell; R A Erger; T B Casale
Journal:  J Immunol Methods       Date:  1996-10-16       Impact factor: 2.303

5.  The induction of eosinophil peroxidase release: improved methods of measurement and stimulation.

Authors:  Darryl J Adamko; Yingqi Wu; Gerald J Gleich; Paige Lacy; Redwan Moqbel
Journal:  J Immunol Methods       Date:  2004-08       Impact factor: 2.303

6.  Eosinophil granulocytes: functional differences of a new isolation kit compared to the isolation with anti-CD16-conjugated MicroBeads.

Authors:  Matthias Schefzyk; Manuela Bruder; Andreas Schmiedl; Michael Stephan; Alexander Kapp; Bettina Wedi; Ulrike Raap
Journal:  Exp Dermatol       Date:  2009-01-21       Impact factor: 3.960

Review 7.  Respiratory viruses and eosinophils: exploring the connections.

Authors:  Helene F Rosenberg; Kimberly D Dyer; Joseph B Domachowske
Journal:  Antiviral Res       Date:  2009-04-16       Impact factor: 5.970

  7 in total
  6 in total

1.  Mouse and human eosinophils degranulate in response to platelet-activating factor (PAF) and lysoPAF via a PAF-receptor-independent mechanism: evidence for a novel receptor.

Authors:  Kimberly D Dyer; Caroline M Percopo; Zhihui Xie; Zhao Yang; John Dongil Kim; Francis Davoine; Paige Lacy; Kirk M Druey; Redwan Moqbel; Helene F Rosenberg
Journal:  J Immunol       Date:  2010-04-26       Impact factor: 5.422

2.  Activation of pulmonary dendritic cells and Th2-type inflammatory responses on instillation of engineered, environmental diesel emission source or ambient air pollutant particles in vivo.

Authors:  Gillina F G Bezemer; Stephen M Bauer; Günter Oberdörster; Patrick N Breysse; Raymond H H Pieters; Steve N Georas; Marc A Williams
Journal:  J Innate Immun       Date:  2010-11-23       Impact factor: 7.349

3.  Eosinophil persistence in vivo and sustained viability ex vivo in response to respiratory challenge with fungal allergens.

Authors:  W E Geslewitz; C M Percopo; H F Rosenberg
Journal:  Clin Exp Allergy       Date:  2017-11-22       Impact factor: 5.018

4.  Purification of functional eosinophils from human bone marrow.

Authors:  Tina W Wong; Diane F Jelinek
Journal:  J Immunol Methods       Date:  2012-10-22       Impact factor: 2.303

5.  Physiologic concentrations of HMGB1 have no impact on cytokine-mediated eosinophil survival or chemotaxis in response to Eotaxin-2 (CCL24).

Authors:  Kimberly D Dyer; Helene F Rosenberg
Journal:  PLoS One       Date:  2015-03-16       Impact factor: 3.240

6.  Frontline Science: Cytokine-mediated developmental phenotype of mouse eosinophils: IL-5-associated expression of the Ly6G/Gr1 surface Ag.

Authors:  Ajinkya R Limkar; Eric Mai; Albert C Sek; Caroline M Percopo; Helene F Rosenberg
Journal:  J Leukoc Biol       Date:  2019-11-01       Impact factor: 6.011

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.